NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $910,000 | -7.9% | 11,400 | 0.0% | 0.12% | -19.0% |
Q1 2018 | $988,000 | +25.5% | 11,400 | 0.0% | 0.15% | +28.6% |
Q4 2017 | $787,000 | -24.0% | 11,400 | 0.0% | 0.12% | -29.2% |
Q3 2017 | $1,036,000 | +22.0% | 11,400 | 0.0% | 0.17% | +33.3% |
Q2 2017 | $849,000 | -20.5% | 11,400 | 0.0% | 0.13% | -37.0% |
Q1 2017 | $1,068,000 | +29.0% | 11,400 | 0.0% | 0.20% | +22.0% |
Q4 2016 | $828,000 | -30.4% | 11,400 | 0.0% | 0.16% | -27.1% |
Q3 2016 | $1,190,000 | – | 11,400 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |